Multiple Myeloma and Malignant Lymphoma
1 competing product in clinical development for Multiple Myeloma and Malignant Lymphoma.
Pipeline by Phase
Phase 21
All Products (1)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| KRN125(pegfilgrastim), PLR001(plerixafor) + KRN8601(filgrastim), PLR001(plerixafor) | Kyowa Kirin | Phase 2 | Completed | 35 |